Insights

Innovative Collaboration DNDi actively partners with biotech firms such as InfYnity Biomarkers and LEO Foundation, indicating openness to collaborations that enhance diagnostic and drug discovery capabilities, creating opportunities to offer innovative solutions and joint development initiatives.

Focus on Neglected Diseases With over 40 projects targeting diseases like leishmaniasis, Chagas, sleeping sickness, and mycetoma, DNDi presents opportunities for suppliers and service providers specializing in diagnostics, treatment delivery, and R&D tools for these underserved markets.

Recent Strategic Initiatives Recent collaborations and breakthroughs, including new diagnostic tools and drug discovery models for mycetoma and lymphatic filariasis, suggest an interest in cutting-edge technologies and solutions that can accelerate development and registration timelines.

Recognition and Funding As a recipient of prestigious awards like the Hideyo Noguchi Africa Prize and with revenue estimates up to 500 million USD, DNDi demonstrates strong credibility and financial capacity, making it a reliable partner for large-scale funding, joint projects, and innovative R&D investments.

Global Impact Focus Operating globally with partnerships across Asia and Africa and a mission to deliver affordable and patient-friendly treatments, DNDi offers opportunities for regional vendors and global solution providers to contribute to sustainable health innovations aimed at neglected populations.

Drugs for Neglected Diseases initiative (DNDi) Tech Stack

Drugs for Neglected Diseases initiative (DNDi) uses 8 technology products and services including Tagetik, TIBCO Spotfire, SAP, and more. Explore Drugs for Neglected Diseases initiative (DNDi)'s tech stack below.

Tagetik

Business Intelligence

TIBCO Spotfire

Business Intelligence

SAP

Customer Relationship Management

Microsoft PowerPoint

Editors

MixItUp

Javascript Frameworks

Priority Hints

Performance

Sprout Social

Social Media Marketing Software

Google Analytics

Web Analytics

Drugs for Neglected Diseases initiative (DNDi) Email Formats	Example	Percentage
FLast@dndi.org	JDoe@dndi.org	50%
FLast@dndi.org	JDoe@dndi.org	50%

Drugs for Neglected Diseases initiative (DNDi) Email Formats

Example

Percentage

FLast@dndi.org

JDoe@dndi.org

50%

FLast@dndi.org

JDoe@dndi.org

50%

Frequently Asked Questions

What is Drugs for Neglected Diseases initiative (DNDi)'s phone number?

You can contact Drugs for Neglected Diseases initiative (DNDi)'s main corporate office by phone at

+41-22-906-9****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Drugs for Neglected Diseases initiative (DNDi)'s official website and social media links?

Drugs for Neglected Diseases initiative (DNDi)'s official website is dndi.org and has social profiles on LinkedIn Crunchbase.

How much revenue does Drugs for Neglected Diseases initiative (DNDi) generate?

As of December 2025, Drugs for Neglected Diseases initiative (DNDi)'s annual revenue is estimated to be $2M.

What is Drugs for Neglected Diseases initiative (DNDi)'s SIC code NAICS code?

Drugs for Neglected Diseases initiative (DNDi)'s SIC code is 8011 - Offices and Clinics of Doctors of Medicine NAICS code is 5417 - Scientific Research and Development Services.

How many employees does Drugs for Neglected Diseases initiative (DNDi) have currently?

As of December 2025, Drugs for Neglected Diseases initiative (DNDi) has approximately 421 employees across 5 continents, including EuropeAsiaSouth America. Key team members include Chief Of Staff: A. F.Head Of Hr & Organisation: S. V.Head Of Drug Discovery - Member Of The Senior Leadership Team: E. C.. Explore Drugs for Neglected Diseases initiative (DNDi)'s employee directory with LeadIQ.

What industry does Drugs for Neglected Diseases initiative (DNDi) belong to?

Drugs for Neglected Diseases initiative (DNDi) operates in the Research Services industry.

What technology does Drugs for Neglected Diseases initiative (DNDi) use?

Drugs for Neglected Diseases initiative (DNDi)'s tech stack includes TagetikTIBCO SpotfireSAPMicrosoft PowerPointMixItUpPriority HintsSprout SocialGoogle Analytics.

What is Drugs for Neglected Diseases initiative (DNDi)'s email format?

Drugs for Neglected Diseases initiative (DNDi)'s email format typically follows the pattern of FLast@dndi.org. Find more Drugs for Neglected Diseases initiative (DNDi) email formats with LeadIQ.

When was Drugs for Neglected Diseases initiative (DNDi) founded?

Drugs for Neglected Diseases initiative (DNDi) was founded in 2003.

Drugs for Neglected Diseases initiative (DNDi)

Research ServicesGeneva, Switzerland201-500 Employees

The Drugs for Neglected Diseases initiative (DNDi) is an international, not-for-profit research and development organization. We discover, develop, and deliver treatments for neglected patients around the world. Our treatments are affordable and patient-friendly – and have already saved millions of lives.

We are researching new treatments for people living with Chagas disease, sleeping sickness (human African trypanosomiasis), leishmaniasis, filarial infections, mycetoma, paediatric HIV, hepatitis C, and dengue. Together with our partners, we are working on over 40 projects, including more than 20 new chemical entities. We are also running over 20 clinical trials.

When the medical humanitarian organization Médecins Sans Frontières (MSF) won the Nobel Peace Prize in 1999, they dedicated a portion of the award to addressing this fatal imbalance and exploring a new, alternative, not-for-profit model for developing drugs for neglected patients. As a result in 2003, MSF, the World Health Organization, and five international research institutions founded DNDi.

Insights

Similar companies to Drugs for Neglected Diseases initiative (DNDi)

Wellcome Trust

FDA

PATH

Bill & Melinda Gates Foundation